Cunning Capital Partners LP Acquires Shares of 52,165 Celestica, Inc. $CLS

Key Points

• Cunning Capital Partners LP has made a new investment in Celestica, purchasing 52,165 shares valued at approximately $4.1 million, making it the firm's 8th biggest position.
• Celestica reported a 21% increase in quarterly revenue year-over-year, outpacing analyst estimates with earnings of $1.39 per share compared to expectations of $1.23.
• Research firms have recently upgraded their ratings on Celestica, with UBS setting a new price target of $208 and Barclays raising it to $220.

Cunning Capital Partners LP purchased a new stake in Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS in the 1st quarter, according to its most recent disclosure with the SEC. The fund purchased 52,165 shares of the technology company's stock, valued at approximately $4,111,000. Celestica accounts for 2.6% of Cunning Capital Partners LP's holdings, making the stock its 8th largest position.

Several other hedge funds and other institutional investors have also modified their holdings of CLS. Barclays PLC boosted its holdings in shares of Celestica by 32.9% in the 4th quarter. Barclays PLC now owns 68,886 shares of the technology company's stock valued at $6,359,000 after buying an additional 17,038 shares during the period. Mariner LLC boosted its holdings in shares of Celestica by 41.0% in the 4th quarter. Mariner LLC now owns 15,794 shares of the technology company's stock valued at $1,459,000 after buying an additional 4,593 shares during the period. NewEdge Advisors LLC boosted its holdings in shares of Celestica by 5.5% in the 4th quarter. NewEdge Advisors LLC now owns 5,400 shares of the technology company's stock valued at $498,000 after buying an additional 281 shares during the period. Tower Research Capital LLC TRC boosted its holdings in shares of Celestica by 596.5% in the 4th quarter. Tower Research Capital LLC TRC now owns 1,393 shares of the technology company's stock valued at $129,000 after buying an additional 1,193 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its holdings in shares of Celestica by 65.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 269,378 shares of the technology company's stock valued at $24,864,000 after buying an additional 106,931 shares during the period. 67.38% of the stock is owned by institutional investors and hedge funds.

Celestica Trading Up 2.1%

Shares of CLS stock traded up $3.95 during trading hours on Monday, reaching $192.87. 1,871,611 shares of the stock traded hands, compared to its average volume of 4,304,058. Celestica, Inc. has a 1-year low of $40.65 and a 1-year high of $218.80. The business has a fifty day moving average price of $171.83 and a 200 day moving average price of $125.51. The company has a quick ratio of 0.86, a current ratio of 1.44 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $22.19 billion, a PE ratio of 41.75 and a beta of 1.80.

Celestica (NYSE:CLS - Get Free Report) TSE: CLS last released its quarterly earnings results on Monday, July 28th. The technology company reported $1.39 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.23 by $0.16. Celestica had a net margin of 5.11% and a return on equity of 28.23%. The business had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.65 billion. During the same quarter in the previous year, the business earned $0.91 earnings per share. The firm's revenue was up 21.0% compared to the same quarter last year. Celestica has set its Q3 2025 guidance at 1.370-1.530 EPS. FY 2025 guidance at 5.500-5.500 EPS. On average, equities research analysts forecast that Celestica, Inc. will post 4.35 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on CLS shares. Wall Street Zen raised shares of Celestica from a "hold" rating to a "buy" rating in a research note on Saturday, August 2nd. Barclays boosted their target price on shares of Celestica from $146.00 to $220.00 and gave the company an "overweight" rating in a research note on Wednesday, July 30th. Argus reduced their target price on shares of Celestica from $150.00 to $120.00 and set a "buy" rating for the company in a research note on Tuesday, April 29th. UBS Group restated a "neutral" rating and set a $208.00 price target (up from $101.00) on shares of Celestica in a research report on Wednesday, July 30th. Finally, BMO Capital Markets restated an "outperform" rating and set a $130.00 price target (up from $118.00) on shares of Celestica in a research report on Thursday, May 22nd. Two analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus target price of $168.92.

About Celestica

Celestica Inc provides supply chain solutions in North America, Europe, and Asia. It operates through two segments: Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.